Intellia Therapeutics, Inc. - Company Filings ↗
| cik | 0001652130 |
| entityType | operating |
| sic | 2835 |
| sicDescription | In Vitro & In Vivo Diagnostic Substances |
| ownerOrg | 03 Life Sciences |
| insiderTransactionForOwnerExists | 0 |
| insiderTransactionForIssuerExists | 1 |
| name | Intellia Therapeutics, Inc. |
| tickers | NTLA |
| exchanges | Nasdaq |
| ein | 364785571 |
| lei | — |
| description | — |
| website | — |
| investorWebsite | — |
| category | Large accelerated filer |
| fiscalYearEnd | 1231 |
| stateOfIncorporation | DE |
| stateOfIncorporationDescription | DE |
| addresses.mailing | street1: 40 ERIE STREET street2: SUITE 130 city: CAMBRIDGE stateOrCountry: MA zipCode: 02139 stateOrCountryDescription: MA isForeignLocation: 0 |
| addresses.business | street1: 40 ERIE STREET street2: SUITE 130 city: CAMBRIDGE stateOrCountry: MA zipCode: 02139 stateOrCountryDescription: MA |
| phone | 857-285-6200 |
| flags | — |
| formerNames | — |